Studylog has been featured in such publications as the following:

Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer

Todd M. Pitts, Erica L. Bradshaw, Stacey M. Bagby, etc. Oncotarget. 2016 Aug 2; 7(31): 50290–50301.


Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways

Hao Zhang, Huanjie Shao, Vita M Golubovskaya, etc. Br J Cancer. 2016 Jul 12; 115(2): 203–211.

Transcriptome profiling of immune tissues reveals habitat‐specific gene expression between lake and river sticklebacks

Yun Huang, Frédéric J. J. Chain, Mahesh Panchal, etc. Mol Ecol. 2016 Feb; 25(4): 943–958.


Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms

Daniel Bedinger, Llewelyn Lao, Shireen Khan, etc. MAbs. 2016 Feb-Mar; 8(2): 389–404.

Effect of a Smac Mimetic (TL32711, Birinapant) on the Apoptotic Program and Apoptosis Biomarkers Examined with Validated Multiplex Immunoassays Fit for Clinical Use

Apurva K. Srivastava, Soumya Jaganathan, Laurie Stephen, etc. Clin Cancer Res. 2016 Feb 15; 22(4): 1000–1010.

CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation

Aldo M. Roccaro, Yuji Mishima, Antonio Sacco, etc. Cell Rep. 2015 Jul 28; 12(4): 622–635.


Viscosity measurements of crystallizing andesite from Tungurahua volcano (Ecuador)

Magdalena Oryaëlle Chevrel, Corrado Cimarelli, Lea deBiasi, etc. Geochem Geophys Geosyst. 2015 Mar; 16(3): 870–889.


p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer

John J. Tentler, Anastasia Ionkina, Aik Choon Tan, etc. Mol Cancer Ther. 2015 May; 14(5): 1117–1129.


Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer

Todd M. Pitts, Timothy P. Newton, Erica L. Bradshaw-Pierce, etc. PLoS One. 2014; 9(11): e113037.


Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle

Francesca Pretto, Carmen Ghilardi, Michele Moschetta, etc. Oncotarget. 2015 Feb; 6(5): 3043–3054.


Antitumor Activity of the MEK Inhibitor TAK-733 Against Melanoma Cell Lines and Patient-Derived Tumor Explants

Lindsey N. Micel, John J. Tentler, Aik Choon Tan, etc. Mol Cancer Ther. 2015 Feb; 14(2): 317–325.

5′-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors*

Keith R. Laderoute, Joy M. Calaoagan, Wan-ru Chao, etc. J Biol Chem. 2014 Aug 15; 289(33): 22850–22864.

Validation of a Hypoxia-Inducible Factor-1α Specimen Collection Procedure and Quantitative ELISA in Solid Tumor Tissues

Sook Ryun Park, Robert J. Kinders, Sonny Khin, etc. Anal Biochem. 2014 Aug 15; 459: 1–11.

Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models

H Zhang, B L Hylander, C LeVea, etc. Br J Cancer. 2014 Jan 21; 110(2): 320–329.


Overcoming IGF1R/IR Resistance Through Inhibition of MEK Signaling in Colorectal Cancer Models

Sara A. Flanigan, Todd M. Pitts, Timothy P. Newton, etc. Clin Cancer Res. 2013 Nov 15; 19(22): 10.1158/1078-0432.CCR-13-0145.

Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy

Changge Fang, Ingalill Avis, David Salomon, etc. J Cancer. 2013; 4(5): 402–415.


Meta‐analytic approaches to determine gender differences in the age‐incidence characteristics of schizophrenia and related psychoses

Dan Jackson, James Kirkbride, Tim Croudace, etc. Int J Methods Psychiatr Res. 2013 Mar; 22(1): 36–45.

Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues

Thomas D. Pfister, Melinda Hollingshead, Robert J. Kinders, etc. PLoS One. 2012; 7(12): e50494.

Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models

Jennifer R. Diamond, S. Gail Eckhardt, Aik Choon Tan, etc. Clin Cancer Res. 2013 Jan 1; 19(1): 291–303.